Cylene Pharmaceuticals Lands $12,000,000 New Funding Round

  • Feed Type
  • Date
    9/27/2010
  • Company Name
    Cylene Pharmaceuticals
  • Mailing Address
    5820 Nancy Ridge Drive San Diego, CA 92121
  • Company Description
    Cylene Pharmaceuticals, Inc. is a privately held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology.
  • Website
    http://www.cylenepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to expand the human clinical trials program for CX-4945, including the Phase I trial in patients with multiple myeloma and a series of randomized Phase II trials.
  • M&A Terms
  • Venture Investor
    Sanderling Ventures
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    Bioventures Investors
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    Mitsui & Co Ltd
  • Venture Investor
    Morningside Group

By posting a comment, you agree to our terms and conditions.